KR102557372B1 - Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient - Google Patents
Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient Download PDFInfo
- Publication number
- KR102557372B1 KR102557372B1 KR1020200188561A KR20200188561A KR102557372B1 KR 102557372 B1 KR102557372 B1 KR 102557372B1 KR 1020200188561 A KR1020200188561 A KR 1020200188561A KR 20200188561 A KR20200188561 A KR 20200188561A KR 102557372 B1 KR102557372 B1 KR 102557372B1
- Authority
- KR
- South Korea
- Prior art keywords
- hair
- extract
- alopecia
- wild
- hair growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 103
- 230000003779 hair growth Effects 0.000 title claims abstract description 71
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 62
- 210000004209 hair Anatomy 0.000 title claims abstract description 56
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 208000024963 hair loss Diseases 0.000 title claims abstract description 39
- 230000003676 hair loss Effects 0.000 title claims abstract description 37
- 239000004480 active ingredient Substances 0.000 title claims abstract description 14
- 230000004936 stimulating effect Effects 0.000 title description 3
- 235000013932 Rosa davurica Nutrition 0.000 title description 2
- 241000675183 Rosa davurica Species 0.000 title description 2
- 230000001737 promoting effect Effects 0.000 claims abstract description 28
- 210000003780 hair follicle Anatomy 0.000 claims abstract description 27
- 210000004027 cell Anatomy 0.000 claims abstract description 25
- 230000004663 cell proliferation Effects 0.000 claims abstract description 22
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 210000002510 keratinocyte Anatomy 0.000 claims abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 231100000360 alopecia Toxicity 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 17
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 16
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims description 15
- 241000218691 Cupressaceae Species 0.000 claims description 14
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 14
- 230000003698 anagen phase Effects 0.000 claims description 10
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 8
- 235000008777 kaempferol Nutrition 0.000 claims description 8
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 8
- 235000001270 Allium sibiricum Nutrition 0.000 claims description 7
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 7
- 230000003658 preventing hair loss Effects 0.000 claims description 7
- 229960001285 quercetin Drugs 0.000 claims description 7
- 235000005875 quercetin Nutrition 0.000 claims description 7
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 6
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 6
- 229920002079 Ellagic acid Polymers 0.000 claims description 6
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 claims description 6
- 229940117893 apigenin Drugs 0.000 claims description 6
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 claims description 6
- 235000008714 apigenin Nutrition 0.000 claims description 6
- 229960002852 ellagic acid Drugs 0.000 claims description 6
- 235000004132 ellagic acid Nutrition 0.000 claims description 6
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 6
- 208000004631 alopecia areata Diseases 0.000 claims description 4
- 208000003024 Diffuse alopecia Diseases 0.000 claims description 3
- 206010068168 androgenetic alopecia Diseases 0.000 claims description 3
- 201000002996 androgenic alopecia Diseases 0.000 claims description 3
- 201000001297 telogen effluvium Diseases 0.000 claims description 3
- 206010001766 Alopecia totalis Diseases 0.000 claims description 2
- 206010001767 Alopecia universalis Diseases 0.000 claims description 2
- 201000009495 Hypotrichosis Diseases 0.000 claims description 2
- 208000006450 Hypotrichosis simplex Diseases 0.000 claims description 2
- 206010043866 Tinea capitis Diseases 0.000 claims description 2
- 208000032775 alopecia universalis congenita Diseases 0.000 claims description 2
- 210000003689 pubic bone Anatomy 0.000 claims description 2
- 241000234435 Lilium Species 0.000 claims 3
- 206010037660 Pyrexia Diseases 0.000 claims 3
- 208000034557 congenital alopecia Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 244000016163 Allium sibiricum Species 0.000 abstract description 12
- 241001465754 Metazoa Species 0.000 abstract description 10
- 235000010379 Allium schoenoprasum var sibiricum Nutrition 0.000 abstract description 7
- 235000003680 wild chives Nutrition 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 4
- 231100001083 no cytotoxicity Toxicity 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 description 23
- 244000184734 Pyrus japonica Species 0.000 description 17
- 238000009472 formulation Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- -1 but not limited to Chemical compound 0.000 description 11
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 10
- 235000013376 functional food Nutrition 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 229960004039 finasteride Drugs 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 6
- 238000011740 C57BL/6 mouse Methods 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 241000234653 Cyperus Species 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 230000003752 improving hair Effects 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000018633 Prunus armeniaca Species 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003778 catagen phase Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940117382 propecia Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 230000003797 telogen phase Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical group NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 230000003775 Anagen V Effects 0.000 description 1
- 230000003777 Anagen VI Effects 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241001504466 Carduelis Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 조성물에 관한 것이다.
본 발명의 생열귀나무 추출물은 세포 독성이 없고, 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하며, 동물 탈모 모델에서 임상적으로 모발 굵기 및 밀도를 증가시켜 발모를 촉진하고, 모낭 수와 bulb 크기도 유의성 있게 증가시키는데 우수한 효과가 있으므로, 의약품, 식품, 및 화장품 분야에서 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진의 목적으로 유용하게 이용 가능하다.The present invention relates to a composition for preventing or treating hair loss, or for promoting hair growth or hair growth, comprising an extract of wild chives as an active ingredient.
The present invention has no cytotoxicity, promotes cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT), and promotes hair growth by increasing hair thickness and density clinically in animal hair loss models And, since it has an excellent effect in significantly increasing the number of hair follicles and bulb size, it can be usefully used for the purpose of preventing or treating hair loss or promoting hair growth or hair growth in the fields of medicine, food, and cosmetics.
Description
본 발명은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing or treating hair loss, or for promoting hair growth or hair growth, comprising an extract of wild chives as an active ingredient.
인체에 있어서 모발은 피부에 있는 모낭에서 자라나며 모발이 자라나는 모낭은 안쪽뿌리 상피집, 바깥뿌리 상피집, 털 줄기, 털 바탕질 등으로 구성된 복잡한 기관으로 일생동안 성장기, 퇴행기, 휴지기 등의 주기가 지속적으로 반복되는 특징이 있다. In the human body, hair grows from hair follicles in the skin, and the hair follicle from which hair grows is a complex organ composed of inner root epithelial sheath, outer root epithelial sheath, hair stem, and hair matrix, and has cycles such as growth, catagen, and telogen throughout life. It is characterized by constant recurrence.
특히, 모낭을 형성하는 세포 중 진피유두 세포는 모발의 성장에 있어서 중요한 역할을 하며, 모낭의 성장기에 진피유두를 둘러싸고 있는 기질의 각질세포를 포함한 모낭의 구성세포들의 증식이 일어난다. 모낭의 퇴행기에는 모낭의 성장이 중단되며 세포사멸(apoptosis)과 진피유두의 응축 및 세포외기질의 재구성이 일어나고 모낭이 다시 성장기로 들어가기 위해 준비하는 단계인 휴지기에는 융기부위를 포함하는 영구적으로 지속되는 부분만이 남아있게 된다.In particular, among the cells forming the hair follicle, dermal papilla cells play an important role in the growth of hair, and proliferation of constituent cells of the hair follicle, including keratinocytes of the matrix surrounding the dermal papilla, occurs during the growth phase of the hair follicle. In the catagen phase of the hair follicle, the growth of the hair follicle stops, apoptosis, condensation of the dermal papilla, and reorganization of the extracellular matrix occur. only remains
탈모란 모낭의 성장주기 중 성장기의 모낭에서 자라는 모발보다 퇴행기 또는 휴지기의 모낭에서 자라는 모발의 비율이 높아져 비정상적으로 빠지는 모발이 증가함을 말한다. 최근 외모를 중시하는 경향이 두드러지면서 탈모에 대한 관심도 증가하고 있다. 이러한 탈모의 원인으로는 혈액순환 불량설, 남성호르몬 작용 과잉설, 피지분비 과잉설, 과산화물과 세균 등에 의한 두피기능 저하설, 유전적 요인, 노화, 스트레스 등등이 논의되었으나, 아직까지 탈모에 대한 명확한 원인은 알려지지 않았다. Hair loss refers to an increase in the number of hairs that fall out abnormally because the ratio of hairs growing from hair follicles in the catagen phase or telogen phase is higher than that of hairs growing in the follicles in the growth phase during the growth cycle of the hair follicle. Recently, as the tendency to emphasize appearance is becoming more prominent, interest in hair loss is also increasing. The causes of such hair loss have been discussed, such as poor blood circulation, excessive action of male hormones, excessive sebum secretion, reduced scalp function due to peroxides and bacteria, genetic factors, aging, stress, etc. The cause is unknown.
일반적으로 탈모의 가장 정형적인 형태는 남성호르몬 작용 과잉으로 나타나는 남성형 탈모증으로 남성호르몬인 안드로겐 의존적으로 발생하며, 대표적인 안드로겐으로는 테스토스테론(testosterone)과 DHT(dihydrotestosterone)가 있는데 탈모환자들인 경우 DHT가 더 많다고 알려져 있다. 테스토스테론은 5알파-환원효소(5-reductase)에 의해 DHT로 전환되고, 이러한 전환은 Type 1과 Type 2의 2가지 형태의 5 알파-환원효소 중 Type 2의 5알파-환원효소에 의하여 일어나며, 전환된 DHT에 의해 진피유두와 모낭의 점진적인 축소화가 진행된다고 보고된 바 있다.In general, the most typical form of hair loss is androgenetic alopecia, which is caused by excessive action of male hormones, and it occurs dependently on androgen, a male hormone. It is known. Testosterone is converted to DHT by 5-reductase, and this conversion occurs by Type 2 5-alpha-reductase among the two types of 5-alpha-reductase, Type 1 and Type 2. It has been reported that gradual miniaturization of dermal papillae and hair follicles is progressed by converted DHT.
이러한 탈모증의 치료 및 예방에 있어서 현재 가장 널리 사용되는 것은 미국 FDA의 승인을 받은 업존사의 미녹시딜(minoxidil) 함유제제이며, 최근에는 머크사에서 Type 2의 5알파-환원효소 억제 효과가 있는 피나스테라이드(finasteride)가 주성분인 프로페시아(Propecia)가 발매되어 사용되고 있다. 이밖에도 크리노스(Crinos, Co.)사의 트리코사카라이드(trichosaccharide) 등을 주성분으로 하는 제제가 사용되고 있다. In the treatment and prevention of such alopecia, the most widely used currently is minoxidil-containing preparations from Upjohn, approved by the US FDA, and recently, finasteride (finasteride), which has an inhibitory effect on type 2 5-alpha-reductase, from Merck. ) is the main ingredient, Propecia, has been released and used. In addition, preparations containing trichosaccharide from Crinos, Co. as a main component are used.
또한, 천연 추출물 기초한 연구들도 진행이 되어, 천궁(특허 제2010-0119761호), 상황버섯(특허 제2012-0038426호), 금은화(특허 제2012-0038426호), 케모마일 등의 추출물(특허 제2012-0015874호, 특허 제2010-0091571호), 하수오(특허 제2013-0021464호, 특허 제2011-0097386호), 창포(특허 제2012-0115980호), 석류(특허 제2012-7012465호), 은행잎 추출물(특허 제2006-7008793호) 등의 결과들이 있다. 그러나 이러한 발모제 혹은 육모제를 실제 임상에서 사용하는 경우 두피에 작용하는 효과가 그다지 탁월하지 못하며, 부작용에 대한 우려 때문에 사용을 꺼리는 미녹시딜이나 프로페시아보다 좀 더 효과가 우수하며 부작용이 적은 천연물질로 이루어진 발모제를 탐색하는 연구가 활발히 진행되고 있다.In addition, studies based on natural extracts have been conducted, and extracts such as Cnidium (Patent No. 2010-0119761), Sanghwang mushroom (Patent No. 2012-0038426), Goldfinch (Patent No. 2012-0038426), and chamomile (Patent No. 2012-0038426). 2012-0015874, Patent No. 2010-0091571), Hasuo (Patent No. 2013-0021464, Patent No. 2011-0097386), Iris (Patent No. 2012-0115980), Pomegranate (Patent No. 2012-7012465), There are results such as ginkgo leaf extract (Patent No. 2006-7008793). However, when these hair restorers or hair restorers are used clinically, the effect on the scalp is not so outstanding, and they are more effective than Minoxidil or Propecia, which are reluctant to use due to concerns about side effects, and hair restorers made of natural substances with fewer side effects. Exploratory research is actively underway.
상기와 같은 배경 하에서, 본 발명자들은 탈모 증상의 예방 또는 치료에 활용하기 위하여 예의 연구 노력한 결과, 생열귀나무 추출물이 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하고, 동물 탈모 모델에서 임상적으로 모발 굵기 및 밀도를 증가시켜 발모를 촉진하며, 모낭 수와 bulb 크기도 유의성 있게 증가시켜, 탈모증 등의 질환 예방 또는 치료에 뛰어난 효과가 있음을 확인하고, 본 발명을 완성하게 되었다.Under the above background, the present inventors have made intensive research efforts to utilize for the prevention or treatment of hair loss symptoms. In a hair loss model, hair growth is promoted by increasing the thickness and density of hair clinically, and the number of hair follicles and bulb size are also significantly increased, confirming that there is an excellent effect in preventing or treating diseases such as alopecia, and completing the present invention. It became.
따라서, 본 발명의 목적은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약제학적 조성물; 탈모 개선용, 또는 발모 또는 육모 촉진용 화장료 조성물; 및 탈모 개선용, 또는 발모 또는 육모 촉진용 식품 조성물을 제공하는 데 있다.Accordingly, an object of the present invention is to provide a pharmaceutical composition for preventing or treating hair loss, or for promoting hair growth or hair growth, comprising an extract of genus japonica as an active ingredient; A cosmetic composition for improving hair loss, or for promoting hair growth or hair growth; And to provide a food composition for improving hair loss, or for promoting hair growth or hair growth.
본 발명의 다른 목적 및 이점은 하기의 발명의 상세한 설명, 청구범위 및 도면에 의해 보다 명확하게 된다.Other objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.
본 발명의 한 양태에 따르면, 본 발명은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학적 조성물을 제공한다.According to one aspect of the present invention, the present invention provides a pharmaceutical composition for preventing or treating hair loss, or for promoting hair growth or hair growth, comprising an extract of Raisinus sinensis as an active ingredient.
본 발명자들은 효과적으로 탈모를 방지하거나 발모 또는 육모를 촉진시킬 수 있는 천연 유래 성분을 발굴하기 위하여 예의 연구노력하였다. 그 결과, 상기 생열귀나무 추출물이 효과적으로 발모 및 육모를 증진하고 탈모를 방지한다는 사실을 확인하였다.The present inventors have made intensive research efforts to discover naturally derived ingredients that can effectively prevent hair loss or promote hair growth or hair growth. As a result, it was confirmed that the extract of the wild rhizome effectively promotes hair growth and hair growth and prevents hair loss.
본 발명의 "생열귀나무(Rosa davurica Pall.)"는 쌍떡잎식물 장미목 장미과의 낙엽관목을 의미한다. 본 발명의 바람직한 실시예에서는 생열귀나무 추출물이 퀘르세틴(Quercetin), 캠퍼롤(Kaempferol 3,4-di-O-glucoside) 엘라그산(Ellagic acid), 및 아피제닌(Apigenin)을 다량으로 함유하고 있는 것을 확인한 바 있다. " Rosa davurica Pall." of the present invention means a deciduous shrub of the dicotyledonous plant Rosaceae Rosaceae. In a preferred embodiment of the present invention, the extract of the wild chives contains a large amount of Quercetin, Kaempferol 3,4-di-O-glucoside, Ellagic acid, and Apigenin. have confirmed that
본 발명에서 사용되는 용어, "추출물"은 생열귀나무의 추출 처리로 얻어지는 추출액, 상기 추출액의 희석액이나 농축액, 상기 추출액을 건조하여 얻어지는 건조물, 상기 추출액의 조정제물이나 정제물, 또는 이들의 혼합물 등, 추출액 자체 및 추출액을 이용하여 형성 가능한 모든 제형의 추출물을 포함한다. 본 발명의 상기 추출물은 바람직하게 추출 후 건조 분말 형태로 제조되어 사용될 수 있다. 상기 생열귀나무의 추출에 있어서, 상기 추출물을 추출하는 방법은 특별히 제한되지 아니하며, 당해 기술 분야에서 통상적으로 사용하는 방법에 따라 추출할 수 있다. 상기 추출방법의 비제한적인 예로는, 열수 추출법, 초음파 추출법, 여과법, 환류 추출법 등을 들 수 있으며, 이들은 단독으로 수행되거나 2종 이상의 추출방법을 병용하여 수행될 수 있다. As used in the present invention, the term "extract" refers to an extract obtained by the extraction treatment of a raw heathen tree, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, a refined or purified product of the extract, or a mixture thereof, etc. , including the extract itself and extracts of all formulations that can be formed using the extract. The extract of the present invention may be preferably prepared and used in the form of a dry powder after extraction. In the extraction of the fresh wild cypress tree, the method for extracting the extract is not particularly limited, and can be extracted according to a method commonly used in the art. Non-limiting examples of the extraction method include a hot water extraction method, an ultrasonic extraction method, a filtration method, a reflux extraction method, and the like, which may be performed alone or in combination with two or more extraction methods.
본 발명에서 상기 생열귀나무를 추출하는데 사용되는 추출 용매의 종류는 특별히 제한되지 아니하며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 추출 용매의 비제한적인 예로는 물; 메탄올, 에탄올, 프로필알코올, 부틸알코올 등의 C1 내지 C4의 저급 알코올; 글리세린, 부틸렌글리콜, 프로필렌글리콜 등의 다가 알코올; 및 메틸아세테이트, 에틸아세테이트, 아세톤, 벤젠, 헥산, 디에틸에테르, 디클로로메탄 등의 탄화수소계 용매; 또는 이들의 혼합물을 사용할 수 있으며, 바람직하게, 물, 저급알코올, 1,3-부틸렌글리콜, 에틸아세테이트를 단독으로 사용하거나 2종 이상 혼합하여 사용할 수 있다. In the present invention, the type of extraction solvent used for extracting the natural heat guava tree is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the extraction solvent include water; C1 to C4 lower alcohols such as methanol, ethanol, propyl alcohol and butyl alcohol; polyhydric alcohols such as glycerin, butylene glycol, and propylene glycol; and hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; Or a mixture thereof may be used, and preferably, water, lower alcohol, 1,3-butylene glycol, and ethyl acetate may be used alone or in combination of two or more.
본 발명에서 열수 추출 또는 냉침 추출한 추출물은 부유하는 고체 입자를 제거하기 위해 여과, 예를 들어 나일론 등을 이용해 입자를 걸러내거나 냉동여과법 등을 이용해 여과한 후, 그대로 사용하거나 이를 동결건조, 열풍건조, 분무건조 등을 이용해 건조하여 사용할 수 있다.In the present invention, the extract obtained by hot water extraction or cold brewing is filtered to remove floating solid particles by filtering out the particles using, for example, nylon or by using cryofiltration, and then used as it is or freeze-dried, hot-air-dried, It can be used after being dried using spray drying or the like.
본 발명에서 사용되는 용어, "분획물"은 여러 다양한 구성성분들을 포함하는 혼합물로부터 특정 성분 또는 특정 성분 그룹을 분리하기 위하여 분획을 수행하여 얻어진 결과물을 의미한다. As used herein, the term "fraction" refers to a product obtained by performing fractionation to separate a specific component or a specific component group from a mixture containing various components.
상기 분획 방법의 비제한적인 예로는, 생열귀나무를 추출하여 얻은 추출물에 소정의 용매를 처리하여 상기 추출물로부터 분획물을 얻는 방법을 들 수 있다. 본 발명에서 상기 분획물을 얻는 데에 사용되는 용매의 종류는 특별히 제한되지 아니하며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 분획 용매의 비제한적인 예로는 물, 알코올 등의 극성 용매; 헥산(Hexane), 에틸아세테이트(Ethyl acetate), 클로로포름(Chloroform), 디클로로메탄(Dichloromethane) 등의 비극성 용매 등을 들 수 있다. 이들은 단독으로 사용되거나 2종 이상 혼합하여 사용될 수 있다. 상기 분획 용매 중 알코올을 사용하는 경우에는 구체적으로는 C1 내지 C4의 알코올을 사용할 수 있다.A non-limiting example of the fractionation method may be a method of obtaining a fraction from the extract by treating the extract obtained by extracting the extract from the extract with a predetermined solvent. In the present invention, the type of solvent used to obtain the fraction is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the fractionation solvent include polar solvents such as water and alcohol; and non-polar solvents such as hexane, ethyl acetate, chloroform, and dichloromethane. These may be used alone or in combination of two or more. When alcohol is used among the fractionation solvents, C1 to C4 alcohols may be specifically used.
본 발명의 상기 생열귀나무의 추출물은 생열귀나무의 전초, 잎, 줄기, 뿌리, 및 열매 중 어느 하나 이상의 부위에서 추출 가능하다. 또한, 상기 생열귀나무 추출물은 천연, 잡종 또는 변종 식물로부터 추출될 수 있고, 식물 조직 배양물에서도 추출 가능하다.The extract of the wild plants of the present invention can be extracted from any one or more parts of the whole plant, leaves, stems, roots, and fruits of the plants. In addition, the extract of the wild plant extract can be extracted from natural, hybrid or mutant plants, and can also be extracted from plant tissue culture.
본 명세서의 용어 “탈모”는 모발이 완전히 두피 밖으로 빠져나오게 되는 현상을 의미한다. 또한, 본 명세서의 용어 “발모”는 두피에서 모발이 나는 것을 의미하고, 본 명세서의 용어 “육모”는 모발의 길이가 길어지는 것을 의미하며 당업계에서 이용하는 또 다른 용어인 “양모”와 동일한 의미로 사용된다. 하기 실시예에서 입증한 바와 같이 본 발명의 생열귀나무 추출물은 모 유두 세포(HHDPC)의 세포 증식을 촉진하고(도 2 참조), 각질형성세포(HaCaT)의 세포 증식을 촉진하며(도 3 참조), 동물 탈모 모델에서 임상적으로 모발 굵기 및 밀도를 증가시켜 발모를 촉진하고(도 4), 모낭 수와 bulb 크기도 유의성 있게 증가시키는 효과가 있음을 확인하였다(도 5).As used herein, the term "hair loss" refers to a phenomenon in which hair completely comes out of the scalp. In addition, the term “hair growth” in the present specification means that hair grows on the scalp, and the term “hair growth” in the present specification means that the length of the hair becomes longer and has the same meaning as “wool”, another term used in the art. is used as As demonstrated in the following examples, the extract of the present invention promotes cell proliferation of hair papilla cells (HHDPC) (see FIG. 2) and promotes cell proliferation of keratinocytes (HaCaT) (see FIG. 3). ), it was confirmed that hair growth was promoted by increasing hair thickness and density clinically in an animal hair loss model (FIG. 4), and the number of hair follicles and bulb size were also significantly increased (FIG. 5).
본 발명의 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학적 조성물에 있어서, 상기 생열귀나무 추출물은 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진한다. In the pharmaceutical composition for preventing or treating hair loss, or for promoting hair growth or hair growth of the present invention, the extract of the wild chive tree promotes cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT).
따라서, 본 발명의 조성물은 다각적이고 안정적인 탈모 예방 또는 치료, 또는 발모 및 양모 촉진 효능을 보이는 효율적인 탈모 예방 또는 치료 조성물, 또는 발모/양모제 조성물로 적용될 수 있다.Therefore, the composition of the present invention can be applied as a multifaceted and stable hair loss prevention or treatment, or an effective hair loss prevention or treatment composition exhibiting hair growth and hair growth promoting effects, or a hair growth / hair growth composition.
본 발명에 따르면, 본 발명의 조성물은 원형 탈모증(alopecia areata), 안드로겐성 탈모증(androgenetic alopecia), 머리 백선(tinea capitis), 감모증(hypotrichosis), 유전성 단순 감모증(hereditary hypotrichosis simplex), 국한 탈모증(circumscribed alopecia), 선천 탈모증(alopecia congenitalis), 두덩탈모증(alopecia pubis), 지루 탈모증(alopecia seborrheica), 노년탈모증(alopecia senilis), 전두 탈모증(alopecia totalis), 전산 탈모증(alopecia universalis), 및 휴지기 탈모증(telogen effluvium)에서 선택된 어느 하나의 탈모증(alopecia)을 치료하는데 사용할 수 있다. According to the present invention, the composition of the present invention is used for the treatment of alopecia areata, androgenetic alopecia, tinea capitis, hypotrichosis, hereditary hypotrichosis simplex, localized alopecia. (circumscribed alopecia), alopecia congenitalis, alopecia pubis, seborrheic alopecia (alopecia seborrheica), senile alopecia (alopecia senilis), alopecia totalis, alopecia universalis, and telogen effluvium It can be used to treat alopecia of any one selected from (telogen effluvium).
본 발명의 조성물이 약제학적 조성물로 제조되는 경우, 본 발명의 약제학적 조성물은 약제학적으로 허용되는 담체를 포함한다. 본 발명의 약제학적 조성물에 포함되는 약제학적으로 허용되는 담체는 제제시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산 칼슘, 알기네이트, 젤라틴, 규산 칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 물, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. 본 발명의 약제학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다. 적합한 약제학적으로 허용되는 담체 및 제제는 Remington's Pharmaceutical Sciences(19th ed., 1995)에 상세히 기재되어 있다.When the composition of the present invention is prepared as a pharmaceutical composition, the pharmaceutical composition of the present invention includes a pharmaceutically acceptable carrier. Pharmaceutically acceptable carriers included in the pharmaceutical composition of the present invention are commonly used in formulation, and include lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, calcium phosphate, alginate, gelatin, including, but not limited to, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil; it is not going to be The pharmaceutical composition of the present invention may further include a lubricant, a wetting agent, a sweetening agent, a flavoring agent, an emulsifying agent, a suspending agent, a preservative, and the like in addition to the above components. Suitable pharmaceutically acceptable carriers and agents are described in detail in Remington's Pharmaceutical Sciences (19th ed., 1995).
본 발명의 약제학적 조성물은 경구 또는 비경구 투여할 수 있으며, 본 발명의 일 구현예에 따르면 비경구 방식으로 투여되고, 본 발명의 다른 구현예에 따르면 경피투여방식으로 투여된다. The pharmaceutical composition of the present invention may be administered orally or parenterally, and according to one embodiment of the present invention, it is administered in a parenteral manner, and according to another embodiment of the present invention, it is administered in a transdermal manner.
본 발명의 약제학적 조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다. 본 발명의 약제학적 조성물의 바람직한 투여량은 성인 기준으로 0.0001-100㎎/kg 범위 내이다.A suitable dosage of the pharmaceutical composition of the present invention is variously prescribed by factors such as formulation method, administration method, patient's age, weight, sex, medical condition, food, administration time, administration route, excretion rate and response sensitivity. It can be. A preferred dosage of the pharmaceutical composition of the present invention is within the range of 0.0001-100 mg/kg for adults.
본 발명의 약제학적 조성물은 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약제학적으로 허용되는 담체 및/또는 부형제를 이용하여 제제화함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기 내에 내입시켜 제조될 수 있다. 이때 제형은 오일 또는 수성 매질 중의 용액, 현탁액, 시럽제 또는 유화액 형태이거나 엑스제, 산제, 분말제, 과립제, 정제 또는 캅셀제 형태일 수도 있으며, 분산제 또는 안정화제를 추가적으로 포함할 수 있다.The pharmaceutical composition of the present invention is prepared in unit dosage form by formulation using a pharmaceutically acceptable carrier and/or excipient according to a method that can be easily performed by those skilled in the art. or it may be prepared by incorporating into a multi-dose container. In this case, the formulation may be in the form of a solution, suspension, syrup or emulsion in an oil or aqueous medium, or may be in the form of an extract, powder, powder, granule, tablet or capsule, and may additionally contain a dispersing agent or stabilizer.
본 발명의 또 다른 양태에 따르면, 본 발명은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 개선용, 또는 발모 또는 육모 촉진용 식품 조성물을 제공한다.According to another aspect of the present invention, the present invention provides a food composition for improving hair loss, or for promoting hair growth or hair growth, comprising an extract of Raisinus sinensis as an active ingredient.
본 발명의 상기 생열귀나무 추출물은 세포 독성이 없고, 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하며, 동물 탈모 모델에서 임상적으로 모발 굵기 및 밀도를 증가시켜 발모를 촉진하고, 모낭 수와 bulb 크기도 유의성 있게 증가시키는 효과가 있으므로, 탈모 예방, 또는 발모 또는 육모 촉진을 위한 식품 조성물로 유용하게 사용될 수 있다. 본 발명의 생열귀나무 추출물과 탈모 예방, 또는 발모 또는 육모 촉진에 대한 효과는 상기에서 설명한 바와 같다. 상기 식품 조성물은 건강기능식품의 형태로 사용될 수 있으나, 이에 제한되는 것은 아니다. The wild chive extract of the present invention has no cytotoxicity, promotes cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT), and increases hair thickness and density clinically in animal hair loss models to promote hair growth It can be usefully used as a food composition for preventing hair loss or promoting hair growth or hair growth because it has the effect of promoting and significantly increasing the number of hair follicles and bulb size. The effects of the extract of the present invention on the prevention of hair loss, or the promotion of hair growth or hair growth are as described above. The food composition may be used in the form of health functional food, but is not limited thereto.
본 발명의 식품 조성물은 생열귀나무 추출물의 분획물 또는 이의 가공물의 형태로 포함될 수 있다. 또한, 상기 조성물은 유효성분 이외에 식품학적으로 허용 가능한 식품보조첨가제를 포함할 수 있다.The food composition of the present invention may be included in the form of a fraction or a processed product of the extract of Saengyeolgi tree. In addition, the composition may include a food additive that is acceptable in food science in addition to the active ingredient.
본 발명에 있어서, "식품보조첨가제"란 식품에 보조적으로 첨가될 수 있는 구성요소를 의미하며, 각 제형의 건강기능식품을 제조하는데 첨가되는 것으로서 당업자가 적절히 선택하여 사용할 수 있다. 식품보조첨가제의 예로는 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 충진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등이 포함되지만, 상기 예들에 의해 본 발명의 식품보조첨가제의 종류가 제한되는 것은 아니다.In the present invention, "food supplement additive" refers to a component that can be added to food supplementally, and can be appropriately selected and used by those skilled in the art as being added to prepare a health functional food of each formulation. Examples of food additives include various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and fillers, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners , pH regulators, stabilizers, preservatives, glycerin, alcohol, carbonation agents used in carbonated beverages, etc. are included, but the types of food additives of the present invention are not limited by the above examples.
본 발명의 식품 조성물에는 건강기능식품이 포함될 수 있다. 본 발명에 있어서, "건강기능식품"이란 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 정제, 캅셀, 분말, 과립, 액상 및 환 등의 형태로 제조 및 가공한 식품을 말한다. 여기서 "기능성"이라 함은 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건 용도에 유용한 효과를 얻는 것을 의미하며, 구체적으로 탈모 예방, 또는 발모 또는 육모 촉진 효과를 의미한다. 본 발명의 건강기능식품은 당업계에서 통상적으로 사용되는 방법으로 제조 가능하며, 상기 제조시에는 당업계에서 통상적으로 첨가하는 원료 및 성분을 첨가하여 제조할 수 있다. The food composition of the present invention may include health functional food. In the present invention, "health functional food" refers to food manufactured and processed in the form of tablets, capsules, powders, granules, liquids and pills using raw materials or ingredients having useful functionality for the human body. Here, "functionality" means obtaining useful effects for health purposes such as regulating nutrients for the structure and function of the human body or physiological functions, and specifically means preventing hair loss, or promoting hair growth or hair growth. The health functional food of the present invention can be prepared by a method commonly used in the art, and can be prepared by adding raw materials and components commonly added in the art during the preparation.
또한, 상기 건강기능식품의 제형 또한 건강기능식품으로 인정되는 제형이면 제한 없이 제조될 수 있다. 본 발명의 식품 조성물은 다양한 형태의 제형으로 제조될 수 있으며, 일반 약품과는 달리 식용가능한 생열귀나무 추출물을 원료로 하여 약품의 장기 복용 시 발생할 수 있는 부작용 등이 없는 장점이 있고, 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하며, 동물 탈모 모델에서 임상적으로 모발 굵기 및 밀도를 증가시켜 발모를 촉진하고, 모낭 수와 bulb 크기도 유의성 있게 증가시키는 효과가 있으므로, 탈모증의 치료 효과를 증진시키기 위한 보조제로 섭취할 수 있다.In addition, the formulation of the health functional food may also be manufactured without limitation as long as the formulation is recognized as a health functional food. The food composition of the present invention can be prepared in various types of dosage forms, and unlike general medicines, it has the advantage of not having side effects that can occur when taking medicines for a long time by using the edible raw extract of wild chives as a raw material. It promotes cell proliferation of (HHDPC) and keratinocytes (HaCaT), promotes hair growth by increasing hair thickness and density clinically in animal hair loss models, and has the effect of significantly increasing the number of hair follicles and bulb size, It can be taken as an adjuvant to enhance the therapeutic effect of alopecia.
본 발명의 건강기능식품이 취할 수 있는 형태에는 제한이 없으며, 통상적인 의미의 식품을 모두 포함할 수 있고, 기능성 식품 등 당업계에 알려진 용어와 혼용하여 사용할 수 있다. 아울러 본 발명의 건강기능식품은 당업자의 선택에 따라 식품에 포함될 수 있는 적절한 기타 보조 성분과 공지의 첨가제를 혼합하여 제조할 수 있다. 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등이 있으며, 본 발명에 따른 생열귀나무 추출물을 주성분으로 하여 제조한 즙, 차, 젤리 및 주스 등에 첨가하여 제조할 수 있다. 또한, 동물을 위한 사료로 이용되는 식품도 포함된다.There is no limit to the form that the health functional food of the present invention can take, and it may include all foods in a conventional sense, and may be used interchangeably with terms known in the art, such as functional foods. In addition, the health functional food of the present invention may be prepared by mixing suitable other auxiliary ingredients and known additives that may be included in food according to the selection of those skilled in the art. Examples of foods that can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, chewing gum, dairy products including ice cream, various soups, beverages, tea, drinks, alcoholic beverages, and There are vitamin complexes, etc., and it can be prepared by adding to juice, tea, jelly, juice, etc. prepared by using the extract of the wild rhizome according to the present invention as a main component. Also included are foods used as feed for animals.
본 발명의 다른 양태에 따르면, 본 발명은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 개선용, 또는 발모 또는 육모 촉진용 화장료 조성물을 제공한다.According to another aspect of the present invention, the present invention provides a cosmetic composition for improving hair loss, or for promoting hair growth or hair growth, comprising an extract of Raisinus sinensis as an active ingredient.
본 발명의 화장료 조성물에 포함되는 성분은 생열귀나무 추출물 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.Ingredients included in the cosmetic composition of the present invention include ingredients commonly used in cosmetic compositions in addition to the extract of the wild chives, for example, antioxidants, stabilizers, solubilizers, common adjuvants such as vitamins, pigments and fragrances, and carriers. includes
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다.The cosmetic composition of the present invention can be prepared in any formulation commonly prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing , It may be formulated as an oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane / May contain a propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizing agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butyl glycol oil, fatty acid esters of glycerol, polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Star cellulose, aluminum metahydroxide, bentonite, agar or tracanth and the like may be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleanser, as carrier components, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 화장료 조성물은 상술한 약제학적 조성물과 유효성분 및 용도를 공통으로 하기 때문에, 상기 약제학적 조성물과의 관계에서 공통된 내용은 본 명세서의 과도한 복잡성을 피하기 위하여, 그 기재를 생략한다.Since the cosmetic composition of the present invention has the above-mentioned pharmaceutical composition and active ingredients and uses in common, the description of the common information in relation to the pharmaceutical composition is omitted in order to avoid excessive complexity of the present specification.
본 발명의 특징 및 이점을 요약하면 다음과 같다:The features and advantages of the present invention are summarized as follows:
(1) 본 발명은 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 조성물을 제공한다.(1) The present invention provides a composition for preventing or treating hair loss, or for promoting hair growth or hair growth, comprising an extract of wild genus japonica as an active ingredient.
(2) 본 발명의 생열귀나무 추출물은 세포 독성이 없고, 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하며, 동물 탈모 모델에서 임상적으로 모발 굵기 및 밀도를 증가시켜 발모를 촉진하고, 모낭 수와 bulb 크기도 유의성 있게 증가시키는데 우수한 효과가 있으므로, 의약품, 식품, 및 화장품 분야에서 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진의 목적으로 유용하게 이용 가능하다.(2) The fresh wild chive extract of the present invention has no cytotoxicity, promotes cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT), and increases hair thickness and density clinically in animal hair loss models. Since it has an excellent effect on promoting hair growth and significantly increasing the number of hair follicles and bulb size, it can be usefully used for the purpose of preventing or treating hair loss or promoting hair growth or hair growth in the fields of medicine, food, and cosmetics.
도 1은 생열귀나무의 추출물의 유효성분들을 HPLC를 사용하여 측정한 결과 그래프이다(맨 위에서부터 표준(A), 전초(B), 잎(C), 줄기(D), 뿌리(E), 및 열매(F)에 대한 그래프이고, Peak 1은 퀘르세틴, peak 2는 캠퍼롤, peak 3은 엘라그산에 대한 피크임).
도 2는 생열귀나무의 추출물의 처리에 따른 모 유두 세포(HHDPC)의 세포 증식 변화를 측정하여 나타낸 그래프이다(A 전초, B 잎, C 줄기, D 뿌리, 및 E 열매).
도 3은 생열귀나무의 추출물의 처리에 따른 각질형성세포(HaCaT)의 세포 증식 변화를 측정하여 나타낸 그래프이다(A 전초, B 잎, C 줄기, D 뿌리, 및 E 열매).
도 4는 동물 탈모 모델에서 생열귀나무 추출물을 도포한 후 모발의 굵기 및 밀도 변화를 비교하여 촬영한 사진이다.
도 5는 동물 탈모 모델에서 생열귀나무 추출물을 도포한 후 조직학적 변화를 촬영한 사진이다. Figure 1 is a graph of the results of measuring the active ingredients of the extract of wild genus japonica using HPLC (from the top, standard (A), outpost (B), leaf (C), stem (D), root (E), and fruit (F), Peak 1 is quercetin, peak 2 is kaempferol, and peak 3 is the peak for ellagic acid).
Figure 2 is a graph showing changes in cell proliferation of hair papilla cells (HHDPC) according to the treatment with the extract of wild genus japonica (A sheath, B leaf, C stem, D root, and E fruit).
Figure 3 is a graph showing changes in cell proliferation of keratinocytes (HaCaT) according to the treatment of extracts of wild genus japonica (A sheath, B leaves, C stems, D roots, and E fruits).
Figure 4 is a photograph taken by comparing the change in thickness and density of hair after applying the extract of wild genus japonica in an animal hair loss model.
Figure 5 is a photograph of histological changes after applying the extract of the wild plant in an animal hair loss model.
이하에서는, 본 발명의 구성을 실시예를 들어 더욱 상세히 설명하지만, 본 발명의 권리범위가 하기에 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예들은 본 발명의 개시가 완전하도록 하고, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다. 또한, 하기에서 기재된 실험 결과에 따른 대조군, 비교군 및 실험군들 간의 유의성은 One-Way ANOVA로 검증하였다.Hereinafter, the configuration of the present invention will be described in more detail with examples, but the scope of the present invention is not limited to the embodiments disclosed below, but will be implemented in various forms different from each other, only the present embodiments It is provided to make the disclosure of the invention complete, and to fully inform those skilled in the art of the scope of the invention to which the present invention belongs, and the present invention is only defined by the scope of the claims. In addition, the significance between the control group, comparison group, and experimental group according to the experimental results described below was verified by One-Way ANOVA.
실시예 1. 생열귀나무 추출물의 제조Example 1. Preparation of extracts of fresh lentil trees
제조예 1-1. 생열귀나무 전초 추출물의 제조Preparation Example 1-1. Preparation of extracts from wild plants
생열귀나무의 전초(원산지: 국내산, 구입처:원삼로즈힙㈜)를 흐르는 물에 세척하여 불순물을 제거한 후, 생열귀나무의 전초 100g에 30% 에탄올 수용액 1L를 가하여 1일간 실온에서 교반한 후 1시간 초음파하여 추출하였다. 상기 과정은 3-Batch로 진행하였다. 얻어진 추출액을 모은 후, 40℃ 이하에서 감압 농축한 후, 동결건조하여 분말형태로 제조하였다(제조예 1).After removing impurities by washing the outposts of the wild plants (origin: domestic, place of purchase: Wonsam Rosehip Co., Ltd.) in running water, 1L of 30% ethanol aqueous solution was added to 100 g of the plants, stirred at room temperature for 1 day, and then stirred for 1 hour. Extracted by sonication. The process was carried out in 3-batch. After collecting the obtained extract, concentrated under reduced pressure at 40 ℃ or less, and then lyophilized to prepare a powder form (Preparation Example 1).
제조예 1-2. 생열귀나무 잎 추출물의 제조Preparation Example 1-2. Manufacture of extracts of wild genus japonica leaves
생열귀나무의 잎을 사용한 것을 제외하고, 상기 제조예 1-1과 동일한 방법으로 생열귀나무 잎 추출물을 제조하였다.Except for the use of the leaves of the wild cypress tree, the extract of the leaf extract of the cypress tree was prepared in the same manner as in Preparation Example 1-1.
제조예 1-3. 생열귀나무 줄기 추출물의 제조Preparation Example 1-3. Manufacture of the extract of the stem of the wild apricot tree
생열귀나무의 줄기를 사용한 것을 제외하고, 상기 제조예 1-1과 동일한 방법으로 생열귀나무 줄기 추출물을 제조하였다.Except for using the stem of Cyperus japonica, the extract of the stem of Cyperus japonica was prepared in the same manner as in Preparation Example 1-1.
제조예 1-4. 생열귀나무 뿌리 추출물의 제조Preparation Example 1-4. Preparation of the extract of the root of the wild apricot tree
생열귀나무의 뿌리를 사용한 것을 제외하고, 상기 제조예 1-1과 동일한 방법으로 생열귀나무 뿌리 추출물을 제조하였다.Except for the use of the root of Cyperus japonica, the extract of the root of Cyperus japonica was prepared in the same manner as in Preparation Example 1-1.
제조예 1-5. 생열귀나무 열매 추출물의 제조Preparation Example 1-5. Preparation of extracts from the fruit of the wild apricot tree
생열귀나무의 열매를 사용한 것을 제외하고, 상기 제조예 1-1과 동일한 방법으로 생열귀나무 열매 추출물을 제조하였다.A fruit extract of the fruit of the fruit of the wild plant was prepared in the same manner as in Preparation Example 1-1, except that the fruit of the plant of the wild plant was used.
실시예 2. 생열귀나무 추출물의 성분분석Example 2. Component analysis of the extract of fresh genus japonica
상기 실시예 1에서 제조한 생열귀나무 추출물들의 지표 성분의 함량을 비교 분석하였다. The content of the indicator component of the extracts of the wild genus japonica prepared in Example 1 was compared and analyzed.
고속 액체크로마토 그래피 분석은 Thermo UHPLC U3000을 사용하였다. HPLC 분석 조건은 다음과 같다. 컬럼은 Sunfire TM C18 column(Waters, 250×4.6mm, 5μm)을 이용하였으며, 컬럼 온도는 25℃로 하였다. UV 파장은 270nm에서 측정하였으며 이동상은 0.1% 포름산이 포함된 물과 아세토나이트릴(gradient mode)을 사용하였다. 상기 실시예 1에서 제조한 생열귀나무 추출물(제조예 1-1 내지 1-5)은 이동상 용매에 5mg/ml의 농도로 용해하여 10uL를 주입한 후 유속 1ml/min으로 측정하였다. 상기 추출물의 지표성분 함량을 하기 [표 1]에 나타내었다.High performance liquid chromatography analysis was performed using Thermo UHPLC U3000. HPLC analysis conditions were as follows. A Sunfire TM C18 column (Waters, 250 × 4.6 mm, 5 μm) was used as the column, and the column temperature was set at 25°C. The UV wavelength was measured at 270 nm, and water containing 0.1% formic acid and acetonitrile (gradient mode) were used as the mobile phase. [0040] The extracts of the wild rhododendron sinensis prepared in Example 1 (Preparation Examples 1-1 to 1-5) were dissolved in a mobile phase solvent at a concentration of 5 mg/ml, and 10 uL was injected, followed by measurement at a flow rate of 1 ml/min. The content of the marker component of the extract is shown in [Table 1].
[표 1][Table 1]
상기 [표 1] 및 [도 1]을 참조하면, 생열귀나무의 전초는 퀘르세틴(Quercetin), 캠퍼롤(Kaempferol 3,4-di-O-glucoside) 엘라그산(Ellagic acid) 및 아피제닌(Apigenin)이 다량 함유되어 있는 것으로 분석되었다. Referring to [Table 1] and [Fig. 1], the outposts of the wild plants are Quercetin, Kaempferol 3,4-di-O-glucoside, Ellagic acid and Apigenin ) was analyzed to contain a large amount.
또한, 다른 부위와 다르게 생열귀나무 잎은 퀘르세틴(Quercetin) 및 캠퍼롤(Kaempferol 3,4-di-O-glucoside)이, 생열귀나무 뿌리는 아피제닌(Apigenin)이 다량 함유되어 있는 것으로 분석되었다. In addition, unlike other parts, it was analyzed that the leaves of the wild cypress tree contain a large amount of quercetin and kaempferol (Kaempferol 3,4-di-O-glucoside), and the roots of the cypress tree contain a large amount of apigenin. .
실험예 1. 모 유두 세포(HHDPC)의 세포 증식 활성 분석을 통한 발모 효능 평가Experimental Example 1. Evaluation of hair growth efficacy through analysis of cell proliferation activity of hair papilla cells (HHDPC)
상기 실시예 1에서 제조된 생열귀나무 추출물(제조예 1-1 내지 제조예 1-5)의 발모 촉진 효능을 확인하기 위하여, 모발 생성에 관여하는 모낭의 모 유두 세포(human hair dermal papilla cell, HHDPC)(Sciencell社, cat. no. 2400)의 세포 증식 활성을 분석함으로써, 생열귀나무 추출물의 발모 효능을 평가하였다.In order to confirm the hair growth stimulating effect of the fresh wild chive tree extract (Preparation Examples 1-1 to 1-5) prepared in Example 1, hair papilla cells of hair follicles involved in hair production (human hair dermal papilla cells, HHDPC) (Sciencell, cat. no. 2400) was analyzed to evaluate the hair growth efficacy of the extracts of the genus Cyperus japonica.
실험은 10% FBS(fetal bovine serum, Cambrex)를 함유한 전용배지인 MSC(Mesenchymal Stem Cell) 배지에 모 유두 세포를 0.25 X 104 cells/㎖ 농도로 96 웰 플레이트에 접종하여 24시간 동안, 37℃, 5% CO2 습윤 조건에서 배양하였다. In the experiment, all papilla cells were inoculated into a 96-well plate at a concentration of 0.25 X 10 4 cells/ml in MSC (Mesenchymal Stem Cell) medium containing 10% FBS (fetal bovine serum, Cambrex), and cultured for 24 hours at 37 °C. ℃, 5% CO 2 It was cultured under humid conditions.
상기 제조예 1-1 내지 제조예 1-5의 생열귀나무 추출물을 각각 0.01, 0.1, 및 1μM 농도로 처리하고, 24, 48, 및 72시간 동안 배양한 후, 5mg/㎖의 MTT[ 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] 시약 20㎕를 상기 배양액에 처리하고, 37℃, 5% CO2 습윤 조건에서 4시간 동안 배양하였다. The extracts from Preparative Examples 1-1 to 1-5 were treated at concentrations of 0.01, 0.1, and 1 μM, respectively, and incubated for 24, 48, and 72 hours, followed by 5 mg/ml MTT [3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] 20 μl of the reagent was treated with the culture solution, and incubated for 4 hours at 37° C. under 5% CO 2 humid conditions.
비교 실험을 위하여 200㎕ 부피의 용매만을 처리한 시험군을 음성대조군으로, 0.08ug/ml의 피나스테라이드(머크)를 처리한 시험군을 양성대조군으로 사용하였다.For comparison experiments, a test group treated with only 200 μl of solvent was used as a negative control group, and a test group treated with 0.08 μg/ml of finasteride (Merck) was used as a positive control group.
배양 중 살아있는 세포는 보라색 크리스탈인 포마잔이 생성된다. 생성된 포마잔을 DMSO 처리를 통해 녹여낸 후, 마이크로플레이트 리더를 사용하여 560nm에서의 흡광도를 측정하여 세포 성장의 정도를 측정하였다. 상기 시험을 3회 반복하였으며, 실험 결과를 도 2에 정리하였다. During cultivation, living cells produce formazan, a purple crystal. After dissolving the produced formazan through DMSO treatment, the degree of cell growth was measured by measuring absorbance at 560 nm using a microplate reader. The test was repeated three times, and the experimental results are summarized in FIG. 2 .
도 2를 참조하면, 생열귀나무 추출물을 처리한 실험군에서는 인간 모 유두 세포의 증식이 촉진되는 현상이 관찰되었는데, 구체적으로 생열귀나무 전초 추출물(제조예 1-1)은 음성대조군과 비교하여 각각의 개선된 세포 증식이 관찰되었으며, 양성대조군인 피나스테라이드 처리군에 비해서도 각각 개선된 세포 증식이 관찰되었다. Referring to FIG. 2, in the experimental group treated with the raw heathen tree extract, it was observed that the proliferation of human hair papilla cells was promoted. Improved cell proliferation was observed, and improved cell proliferation was also observed compared to the finasteride-treated group, which is a positive control group.
또한, 생열귀나무 각 부위별 추출물도 모두 인간 모 유두 세포의 증식을 효과적으로 촉진하였는데, 모든 부위의 추출물을 처리함에 따라 음성대조군과 비교하여 모 유두 세포의 증식이 현저하게 개선되는 현상이 관찰되었다. In addition, all the extracts from each part of the wild plant extracts effectively promoted the proliferation of human hair papilla cells, and as the extracts from all parts were treated, the proliferation of hair papilla cells was remarkably improved compared to the negative control group.
상기 실험 결과를 통해 본 발명의 생열귀나무 추출물은 모 유두 세포의 성장 촉진을 통해 탈모증 등의 질환에 대한 예방 또는 치료에 효과적으로 사용될 수 있음을 확인할 수 있었다(도 2 참조).Through the above experimental results, it was confirmed that the extract of the present invention can be effectively used for preventing or treating diseases such as alopecia by promoting the growth of hair papilla cells (see FIG. 2).
실험예 2. 사람의 각질형성세포(HaCaT cell) 성장에 미치는 영향 평가Experimental Example 2. Evaluation of the effect on the growth of human keratinocytes (HaCaT cell)
상기 실시예 1에서 제조된 생열귀나무 추출물의 발모 촉진 효능을 확인하기 위하여, 모발의 구성 세포인 각질형성세포(HaCaT)의 세포 증식 활성을 분석함으로써, 생열귀나무 추출물의 발모 효능을 평가하였다. In order to confirm the hair growth promoting effect of the extract prepared in Example 1, the cell proliferation activity of keratinocytes (HaCaT), which are constitutive cells of hair, was analyzed to evaluate the hair growth efficacy of the extract.
실험은 모 유두 세포 대신 각질형성세포(HaCaT)(Dr. N. E. Fuseing, Heidelberg, Germany)를 사용하고, 배지를 10% FBS(fetal bovine serum, Cambrex)가 포함된 RPMI 배지를 사용한 것을 제외하고, 상기 실험예 1과 동일한 방법으로 평가하였으며, 실험 결과를 도 3에 정리하였다.The experiment was performed as described above, except that keratinocytes (HaCaT) (Dr. N. E. Fuseing, Heidelberg, Germany) were used instead of hair papilla cells and RPMI medium containing 10% FBS (fetal bovine serum, Cambrex) was used. It was evaluated in the same way as Experimental Example 1, and the experimental results are summarized in FIG. 3.
도 3을 참조하면, 생열귀나무 추출물을 처리한 실험군에서는 각질형성세포(HaCaT)의 증식이 촉진되는 현상이 관찰되었는데, 구체적으로 생열귀나무 전초 추출물(제조예 1-1)은 음성대조군과 비교하여 각각 95%(0.01μM), 110%(0.1μM), 및 120%(1μM) 개선된 세포 증식이 관찰되었고, 양성대조군인 피나스테라이드 처리군에 비해서도 각각 95%(0.01μM), 110%(0.1μM), 및 125%(1μM) 개선된 세포 증식이 관찰되었다. Referring to FIG. 3, in the experimental group treated with the raw heathen tree extract, it was observed that the proliferation of keratinocytes (HaCaT) was promoted. 95% (0.01 μM), 110% (0.1 μM), and 120% (1 μM) improved cell proliferation were observed, respectively, and 95% (0.01 μM), 110% (0.1 μM), respectively, compared to the positive control finasteride-treated group. μM), and 125% (1 μM) improved cell proliferation was observed.
또한, 생열귀나무 각 부위별 추출물도 모두 각질형성세포(HaCaT)의 증식을 효과적으로 촉진하였는데, 구체적으로 생열귀나무 잎 추출물(제조예 1-2)은 음성대조군과 비교하여 각각 90%(0.01μM), 115%(0.1μM), 및 110%(1μM) 개선된 세포 증식이 관찰되었고, 생열귀나무 줄기 추출물(제조예 1-3)은 음성대조군과 비교하여 각각 90%(0.01μM), 95%(0.1μM), 및 100%(1μM) 개선된 세포 증식이 관찰되었으며, 생열귀나무 뿌리 추출물(제조예 1-4)은 음성대조군과 비교하여 각각 90%(0.01μM), 110%(0.1μM), 및 105%(1μM) 개선된 세포 증식이 관찰되었고, 생열귀나무 열매 추출물(제조예 1-5)은 음성대조군과 비교하여 각각 100%(0.01μM), 105%(0.1μM), 및 115%(1μM) 개선된 세포 증식이 관찰되었다. In addition, all the extracts from each part of the wild chive tree effectively promoted the proliferation of keratinocytes (HaCaT). ), 115% (0.1 μM), and 110% (1 μM) improved cell proliferation was observed, and the fresh radishes stem extract (Preparation Example 1-3) was 90% (0.01 μM) and 95%, respectively, compared to the negative control. % (0.1 μM), and 100% (1 μM) improved cell proliferation was observed, and the extracts from the roots of wild chives (Preparation Examples 1-4) were 90% (0.01 μM) and 110% (0.1 μM) compared to the negative control, respectively. μM), and 105% (1μM) improved cell proliferation was observed, and the extracts of the fruit extracts (Preparation Examples 1-5) were 100% (0.01μM), 105% (0.1μM), 105% (0.1μM), and 115% (1 μM) improved cell proliferation was observed.
상기 실험 결과를 통해 본 발명의 생열귀나무 추출물이 각질형성세포(HaCaT)의 성장 촉진을 통해 탈모증 등의 질환에 대한 예방 또는 치료에 효과적으로 사용될 수 있음을 확인할 수 있었다(도 3 참조).Through the above experimental results, it was confirmed that the extract of the present invention can be effectively used for preventing or treating diseases such as alopecia by promoting the growth of keratinocytes (HaCaT) (see FIG. 3).
실험예 3. 동물 탈모 모델(C57BL/6 마우스)에서의 모발 생장 평가Experimental Example 3. Evaluation of hair growth in an animal hair loss model (C57BL/6 mouse)
앞서 검증된 생열귀나무 추출물의 발모 촉진 효능을 육안으로 평가하기 위하여, 동물 탈모 모델에 적용하였다.In order to visually evaluate the hair growth promoting efficacy of the previously verified extract of wild genus japonica, it was applied to an animal hair loss model.
본 실험에 적용하는 탈모 모델은 탈모와 관계된 각종 연구와 실험에서 가장 일반적으로 적용되는 C57BL/6 마우스 탈모 모델을 채택하였다. As the hair loss model applied in this experiment, the C57BL/6 mouse hair loss model, which is most commonly applied in various studies and experiments related to hair loss, was adopted.
7주령 마우스의 등쪽 털에 제모 크림을 바른 후, 털을 제거하면 동시에 모발이 생장기로 유도되는데, 이때 적절한 약물을 도포하여 생장기 모발이 더욱 잘 자라는지 여부(모발생장 증가; raising proliferlation rates)를 확인할 수 있는 방법이다. 참고로, 일반적인 C57BL/6 마우스의 피부색 변화는 9일째 anagen 5기에 진입하면서 회색빛에서 검은색으로 바뀌기 시작하여 14일에서 16일째에는 anagen 6기로서 가장 활발하게 모발 성장이 진행되는 시기이다.Hair removal cream is applied to the dorsal hair of a 7-week-old mouse, and hair is removed at the same time as hair is induced to the anagen phase. way you can For reference, the skin color change of a typical C57BL/6 mouse starts to change from gray to black as it enters anagen stage 5 on day 9, and from day 14 to day 16 is anagen stage 6, which is the period in which hair growth proceeds most actively.
실험을 위해 7주령의 C57BL/6 마우스의 등 부위 털을 제거하고, 등 부위 피부가 깨끗한 마우스를 5마리씩 3개의 군(A-C군)으로 나누었다. 모든 군은 Wax-Rosin 혼합물을 이용하여 모낭을 파괴한 후, 제A군은 식염수를 18일 동안 경구 투여하였고(음성 대조군), 제B군은 머크사에서 개발한 프로페시아(피나스테라이드)를 0.5mg/kg의 용량으로 18일동안 경구 투여 하였으며(양성 대조군), 제C군은 생열귀나무 추출물(제조예 1-1)을 식염수에 녹여 5mg/kg의 용량으로 18일 동안 경구 투여 하였다. 투여 12일 경과 시점의 모발 분포 정도를 촬영한 사진을 도 4에 정리하였다.For the experiment, the hair on the back of 7-week-old C57BL/6 mice was removed, and mice with clean back skin were divided into 3 groups (groups A-C) of 5 mice each. After destroying hair follicles in all groups using the Wax-Rosin mixture, Group A was orally administered with saline for 18 days (negative control group), and Group B was administered Propecia (finasteride) developed by Merck at 0.5 mg/day. It was orally administered for 18 days at a dose of kg (positive control group), and group C was orally administered for 18 days at a dose of 5 mg / kg by dissolving the extract (Preparation Example 1-1) in saline. Pictures taken of the degree of hair distribution at the time of 12 days after administration are summarized in FIG. 4 .
도 4를 참조하면, 본 발명의 생열귀나무 추출물을 처리한 마우스는 피부색이 단시간에 검게 변하고, 털이 빨리 자라며, 실제 피부조직에서도 모낭의 수가 현저히 증가하고 정상 모발의 형태를 유지함이 확인되었는데, 음성대조군(Control)에 비하여 약 3일 정도의 모성장기가 촉진되는 효과를 나타냈다. Referring to FIG. 4, it was confirmed that the skin color of the mouse treated with the extract of the present invention turned black in a short time, the hair grew quickly, and the number of hair follicles significantly increased in the actual skin tissue and maintained the normal hair shape. Compared to the control group, it showed an effect of promoting hair growth for about 3 days.
또한, 본 발명의 생열귀나무 추출물을 도포한 그룹은 양성대조군인 피나스테라이드를 도포한 그룹에 비해 약 1일 정도로 모성장기가 촉진됨을 확인할 수 있었다.In addition, it was confirmed that the hair growth period of the group applied with the extract of the present invention was accelerated by about 1 day compared to the group applied with finasteride, which is a positive control group.
정리하면, 마우스의 모성장기를 촉진하는 것은, 생열귀나무 추출물이 모성장기 촉진과 성장기 유지에 유의적인 효과가 있음을 의미하며, 상기 결과를 통해 본 발명의 생열귀나무 추출물이 발모 촉진에 효과가 있음을 임상적으로 확인할 수 있었다.In summary, stimulating the hair growth of mice means that the extract of the wild chives has a significant effect on the promotion of the hair growth and the maintenance of the growing period, and through the above results, the extract of the hair growth of the present invention is effective in promoting hair growth. It was confirmed clinically that
실험예 4. 조직학적 관찰 평가Experimental Example 4. Histological observation evaluation
상기 실험예 3에서 분석된 C57BL/6 마우스 탈모 모델에서 제모를 통한 생장기 유도 후, 생열귀나무 추출물을 도포한 피부 내 모낭(hair follicle)의 변화, 피부 두께 및 조직의 변화를 관찰하였다.After induction of anagen through hair removal in the C57BL/6 mouse hair loss model analyzed in Experimental Example 3, changes in hair follicles, skin thickness, and tissue in the skin to which the fresh genus japonica extract was applied were observed.
구체적으로는, C57BL/6 마우스 탈모 모델에서 21일째에 각 군의 마우스를 치사시킨 후, 등 쪽 피부의 발모된 부위의 조직을 채취하여 4% 포름알데히드 용액으로 고정하였다. 고정 후, 수세, 탈수과정을 거쳐 파라핀으로 포매하고, 7㎛의 절편을 제작하여 Hematoxylin & Eosin(H&E) 방법으로 염색한 후, 현미경으로 관찰하였다. Specifically, mice in each group were killed on day 21 in the C57BL/6 mouse hair loss model, and then tissues of the hair-growth region of the back skin were collected and fixed with a 4% formaldehyde solution. After fixation, water washing and dehydration were carried out, embedding in paraffin, and 7 μm sections were prepared, stained with Hematoxylin & Eosin (H&E) method, and observed under a microscope.
관찰 결과, 생열귀나무 추출물 처리에 의해 모낭의 길이가 길어져 성장기의 모낭 형태를 나타냈고, 모낭의 수와 bulb의 크기도 유의성 있게 증가한 것을 확인하였다(도 5 참조). As a result of the observation, it was confirmed that the length of the hair follicles was increased by the treatment with the extract of the genus japonica extract, showing the shape of the hair follicles in the growth phase, and the number of hair follicles and the size of the bulb significantly increased (see FIG. 5).
또한, ‘성장기(Anagen) 모발/휴지기(Telogen) 모발’의 비율이 3.5배로 증가한 것을 확인할 수 있었다.In addition, it was confirmed that the ratio of ‘anagen hair/telogen hair’ increased by 3.5 times.
상기와 같은 결과를 통해 본 발명의 생열귀나무 추출물이 모낭 수와 bulb 크기를 증가시키고, 성장기 모발의 비율을 증가시켜 발모 촉진 및 탈모 방지에 효과적임을 확인할 수 있었다. Through the above results, it was confirmed that the extract of the present invention increases the number of hair follicles and bulb size, and increases the ratio of anagen hair to be effective in promoting hair growth and preventing hair loss.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.Having described specific parts of the present invention in detail above, it is clear that these specific techniques are merely preferred embodiments for those skilled in the art, and the scope of the present invention is not limited thereto. Accordingly, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
Claims (6)
상기 생열귀나무 추출물은 생열귀나무의 전초 부위에서 에탄올을 용매로 추출한 생열귀나무 추출물이고,
상기 생열귀나무 추출물은 퀘르세틴(Quercetin), 캠퍼롤(Kaempferol 3,4-di-O-glucoside) 엘라그산(Ellagic acid) 및 아피제닌(Apigenin) 성분을 함유하며,
상기 생열귀나무 추출물은 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하는 것을 특징으로 하고,
상기 생열귀나무 추출물이 모낭 수와 bulb 크기를 증가시키고, 성장기 모발의 비율을 증가시키는 것을 특징으로 하는,
탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학적 조성물.Including the extract of the wild cypress tree as an active ingredient,
The extract of the wild cypress tree is an extract obtained by extracting ethanol as a solvent from the outpost part of the cypress tree,
The fresh fever lily extract contains Quercetin, Kaempferol 3,4-di-O-glucoside, Ellagic acid and Apigenin components,
The extract of the raw heathen tree is characterized in that it promotes the cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT),
Characterized in that the extract of the wild genus chinensis increases the number of hair follicles and the size of the bulb, and increases the ratio of anagen hair,
A pharmaceutical composition for preventing or treating hair loss, or for promoting hair growth or hair growth.
상기 조성물은 원형 탈모증(alopecia areata), 안드로겐성 탈모증(androgenetic alopecia), 머리 백선(tinea capitis), 감모증(hypotrichosis), 유전성 단순 감모증(hereditary hypotrichosis simplex), 국한 탈모증(circumscribed alopecia), 선천 탈모증(alopecia congenitalis), 두덩탈모증(alopecia pubis), 지루 탈모증(alopecia seborrheica), 노년탈모증(alopecia senilis), 전두 탈모증(alopecia totalis), 전신 탈모증(alopecia universalis), 및 휴지기 탈모증(telogen effluvium)에서 선택된 어느 하나의 탈모증(alopecia)을 치료하는 것을 특징으로 하는,
탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학적 조성물.According to claim 1,
The composition is effective against alopecia areata, androgenetic alopecia, tinea capitis, hypotrichosis, hereditary hypotrichosis simplex, circumscribed alopecia, and congenital alopecia. (alopecia congenitalis), alopecia pubis, seborrheic alopecia (alopecia seborrheica), senile alopecia (alopecia senilis), alopecia totalis, alopecia universalis, and telogen effluvium. Characterized in treating one alopecia,
A pharmaceutical composition for preventing or treating hair loss, or for promoting hair growth or hair growth.
상기 생열귀나무 추출물은 생열귀나무의 전초 부위에서 에탄올을 용매로 추출한 생열귀나무 추출물이고,
상기 생열귀나무 추출물은 퀘르세틴(Quercetin), 캠퍼롤(Kaempferol 3,4-di-O-glucoside) 엘라그산(Ellagic acid) 및 아피제닌(Apigenin) 성분을 함유하며,
상기 생열귀나무 추출물은 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하는 것을 특징으로 하고,
상기 생열귀나무 추출물이 모낭 수와 bulb 크기를 증가시키고, 성장기 모발의 비율을 증가시키는 것을 특징으로 하는,
탈모 예방용, 또는 발모 또는 육모 촉진용 식품 조성물.Including the extract of the wild cypress tree as an active ingredient,
The extract of the wild cypress tree is an extract obtained by extracting ethanol as a solvent from the outpost part of the cypress tree,
The fresh fever lily extract contains Quercetin, Kaempferol 3,4-di-O-glucoside, Ellagic acid and Apigenin components,
The raw heat chive extract is characterized in that it promotes the cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT),
Characterized in that the extract of the wild genus chinensis increases the number of hair follicles and the size of the bulb, and increases the ratio of anagen hair,
A food composition for preventing hair loss, or for promoting hair growth or hair growth.
상기 생열귀나무 추출물은 생열귀나무의 전초 부위에서 에탄올을 용매로 추출한 생열귀나무 추출물이고,
상기 생열귀나무 추출물은 퀘르세틴(Quercetin), 캠퍼롤(Kaempferol 3,4-di-O-glucoside) 엘라그산(Ellagic acid) 및 아피제닌(Apigenin) 성분을 함유하며,
상기 생열귀나무 추출물은 모 유두 세포(HHDPC) 및 각질형성세포(HaCaT)의 세포 증식을 촉진하는 것을 특징으로 하고,
상기 생열귀나무 추출물이 모낭 수와 bulb 크기를 증가시키고, 성장기 모발의 비율을 증가시키는 것을 특징으로 하는,
탈모 예방용, 또는 발모 또는 육모 촉진용 화장료 조성물.Including the extract of the wild cypress tree as an active ingredient,
The extract of the wild cypress tree is an extract obtained by extracting ethanol as a solvent from the outpost part of the cypress tree,
The fresh fever lily extract contains Quercetin, Kaempferol 3,4-di-O-glucoside, Ellagic acid and Apigenin components,
The raw heat chive extract is characterized in that it promotes the cell proliferation of hair papilla cells (HHDPC) and keratinocytes (HaCaT),
Characterized in that the extract of the wild genus chinensis increases the number of hair follicles and the size of the bulb, and increases the ratio of anagen hair,
A cosmetic composition for preventing hair loss, or for promoting hair growth or hair growth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200188561A KR102557372B1 (en) | 2020-12-30 | 2020-12-30 | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200188561A KR102557372B1 (en) | 2020-12-30 | 2020-12-30 | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220096277A KR20220096277A (en) | 2022-07-07 |
KR102557372B1 true KR102557372B1 (en) | 2023-07-19 |
Family
ID=82398983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200188561A Active KR102557372B1 (en) | 2020-12-30 | 2020-12-30 | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102557372B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102558832B1 (en) * | 2022-09-28 | 2023-07-25 | (주)메디치코리아코스메틱 | Composition for hair decoloration agent |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101315969B1 (en) * | 2011-06-30 | 2013-10-08 | 주식회사 이롬 | Composition for prevention of hair loss and promotion of hair growth which contains rosa multiflora extract as an active ingredient |
-
2020
- 2020-12-30 KR KR1020200188561A patent/KR102557372B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20220096277A (en) | 2022-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101221417B1 (en) | Composition including ginseng berry extract for promoting hair growth | |
KR102327237B1 (en) | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Complex Extracts of Beet, Red Onion, and Purple Sweet Potato as an Active Ingredient | |
KR20150050310A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
KR101686008B1 (en) | Composition comprising extract of herbal mixture for preventing alopecia or hair growth effect | |
JP6709783B2 (en) | Composition for preventing hair loss or promoting hair growth containing alpine wormwood extract | |
KR102276483B1 (en) | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Complex Extracts of Prunellae spica, Polygonum cuspidata, and Cnidium officinale as an Active Ingredient | |
KR102557372B1 (en) | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Extracts of Rosa davurica Pall as Active Ingredient | |
KR102326086B1 (en) | Composition for Improving Skin Conditions Having Skin Whitening, Moisturizing, Anti-Wrinkle and Skin Barrier Property Comprising Complex Extracts of Broussonetia kazinoki as Active Ingredient | |
KR101203504B1 (en) | Composition for Wrinkle-Care or Skin Whitening Containing Fermentation Liquor of Extract from Stewartia koreana | |
KR20210131598A (en) | Composition for preventing hair loss or promoting hair growth, comprising Camellia japonica pericarp extract as an active ingredient | |
KR20220063388A (en) | Cosmetic composition comprising glutathione, Maqui Berry extract and Mulberry root extract | |
KR20220038892A (en) | Composition for preventing hail loss and improving hair growth | |
KR101740970B1 (en) | Topical composition comprising the herbal mixed extract including phytoncide of Chamaecyparis obtusa showing hair-growth stimulating activity and preventing effect on hair loss | |
KR101512811B1 (en) | Cosmetic Composition Comprising Reynoutria japonica for. elata Extract for Skin Whitening | |
KR20100110407A (en) | Cosmetic composition comprising the herbal mixed extract showing hair-growth stimulating activity and preventing effect on hair loss | |
KR20170065956A (en) | A composition comprising bark of Cinnamomum loureirii extract having anti-oxidative or anti-inflammatory activity | |
KR102705253B1 (en) | Cosmetic Composition for Scalp and Hair Improvement Comprising Plant Complex Extract as an Active Ingredient | |
KR102292114B1 (en) | Composition for Improving Skin Conditions Having Moisturizing, Anti-Inflammatory Caused by Fine Dust and Pore Shrinkage Property Comprising Plant Complex Extracts as Active Ingredient | |
JP6669786B2 (en) | Cosmetic composition for skin whitening containing root extract | |
KR20230042677A (en) | Composition for Preventing or Treating Hair Loss, Stimulating Hair Sprouting or Hair Growth, and alleviating inflammation Comprising Complex Extracts of Panax ginseng, Salvia miltiorrhiza, Sophora flavescens, and Scrophularia buergeriana as an Active Ingredient | |
KR20150010530A (en) | A cosmetic composition comprising critical extracts of pear | |
JP5866139B2 (en) | Pleurotus extract used in pharmaceutical and cosmetic compositions | |
KR102821283B1 (en) | Cosmetic composition for preventing hair loss or promoting hair growth with plant extract as an active ingredient | |
KR102815120B1 (en) | Compositions for cleansing and relieving hair loss, comprising Persicaria perfoliata extract as an active ingredient | |
KR101434300B1 (en) | Cosmetic Composition Comprising Vitis flexuosa Thunb, Penthorum chinense PURSH Extract for Skin Whitening |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20201230 |
|
PA0201 | Request for examination | ||
PN2301 | Change of applicant |
Patent event date: 20210106 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221118 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230530 |
|
PG1601 | Publication of registration |